In the high-stakes arena of biotechnological and medical devices startups, the CEO’s role transcends the realms of innovation and enters the intricate world of financial strategy.
Capital Efficiency is the lifeline that financially sustains innovation and propels growth in the intricate world of biotech startups. Any seasoned CEO has witnessed the transformative power of strategic synergies and prudent practices in steering DeepTech ventures towards impact and success.
Strategic Synergies and Prudent Practices: The Path to Capital Efficiency in Biotech Read More »
Nuestra compañía ha sido elegida como uno de los proyectos más innovadores parar representar a nuestro ecosistema empresarial en el “Foro Región de Murcia, destino inversor”, organizado por El Confidencial.
Viva in Vitro en Foro Región de Murcia: destino inversor Read More »
Dr Rebecca Coll (Queen’s University Belfast) has joined Viva’s Scientific and Advisory Committee, which continues to be strengthened following the addition of Dr Eduardo Lopez Collazo in January.
Dr. Eduardo López Collazo has signed an agreement with Viva In Vitro to become a member of its Advisory and Scientific Committee, thus reinforcing a project that seeks to generate an important impact in the field of inflammasome biomedicine focused on the development of solutions and services for research, pharmaceutical companies and hospitals.
Viva incorporates Dr. Eduardo López Collazo into its Advisory and Scientific Committee Read More »
Our company has been recognised as one of the #TOP100 best startups of 2023, according to the Association of Science and Technology Parks of Spain (APTE).
Viva in Vitro is chosen by APTE as one of the TOP 100 Startups 2023 Read More »
Viva in Vitro achieves ENISA certification as an emerging biotechnology company, leader in sepsis research.
La empresa Viva In Vitro Diagnostics, SL, ha sido reconocida con el prestigioso Premio Empresarial CEI Mare Nostrum en la ceremonia de los II Premios Mare Nostrum en Murcia. Este reconocimiento destaca la destacada labor de Viva In Vitro en el campo de la innovación y la tecnología, particularmente en su esfuerzo por abordar un
The emerging biomedical company Viva in Vitro has moved from the Murcian Institute of Health Research (IMIB) to its new headquarters, inaugurated today at the Murcia Science Park.
Viva in Vitro Opens New Facilities at the Murcia Science Park Read More »
Viva in Vitro amplía su equipo científico atrayendo talento expatriado
Viva in Vitro amplía su equipo científico atrayendo talento expatriado Read More »
Subscribe to VIVA Insights: The leading newsletter on inflammasomes and sepsis
Receive exclusive analysis, scientific breakthroughs and collaboration opportunities from our network of international partners and benchmarks.
